Cargando…

Vasodilation through levodopa for Parkinson's disease may require high left ventricular assist device flow

We report implantation of a left ventricular assist device (LVAD) in a patient with Parkinson's disease. Postoperative fluid overload together with insufficient LVAD output in the setting of vasodilation through levodopa likely caused renal hypoperfusion and acute kidney injury. A patient like...

Descripción completa

Detalles Bibliográficos
Autores principales:	den Uil, Corstiaan A., Friesema, Edith C. H., Constantinescu, Alina A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594037/ https://www.ncbi.nlm.nih.gov/pubmed/30847947 http://dx.doi.org/10.1111/jocs.14012

Ejemplares similares

Monitoring pulmonary pressures during long‐term continuous‐flow left ventricular assist device and fixed pulmonary hypertension: redefining alleged pathophysiological mechanisms?
por: De Bakker, Chantal C., et al.
Publicado: (2020)

Pulmonary vasodilator use in continuous-flow left ventricular assist device management
por: Pirlamarla, Preethi, et al.
Publicado: (2021)

Design and rationale of haemodynamic guidance with CardioMEMS in patients with a left ventricular assist device: the HEMO‐VAD pilot study
por: Veenis, Jesse F., et al.
Publicado: (2019)

Cocaine/amphetamine-induced accelerated atherosclerosis, coronary spasm and thrombosis, and refractory ventricular fibrillation
por: den Uil, Corstiaan A, et al.
Publicado: (2019)

Conventional Hemodynamic Resuscitation May Fail to Optimize Tissue Perfusion: An Observational Study on the Effects of Dobutamine, Enoximone, and Norepinephrine in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock
por: den Uil, Corstiaan A., et al.
Publicado: (2014)

Relapsing low-flow alarms due to suboptimal alignment of the left ventricular assist device inflow cannula
por: Zijderhand, Casper F, et al.
Publicado: (2022)

Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson’s Disease
por: Conti, Valeria, et al.
Publicado: (2022)

Outcomes of continuous flow left ventricular assist device after surgical left ventricular restoration
por: Gyoten, Takayuki, et al.
Publicado: (2023)

Continuous flow left ventricular assist devices and gastrointestinal bleeding
por: Turner, Katja R
Publicado: (2012)

Continuous levodopa for advanced Parkinson’s disease
por: Lundqvist, Christofer
Publicado: (2007)

Levodopa-Responsive Benign Tremulous Parkinsonism
por: Kano, Osamu, et al.
Publicado: (2013)

Mortality in Levodopa-Treated Parkinson's Disease
por: Morgan, John C., et al.
Publicado: (2014)

Levodopa-Carbidopa Intestinal Gel may improve treatment-resistant freezing of gait in Parkinson’s disease
por: Shackleford, Melanie R., et al.
Publicado: (2022)

Left Ventricular Recovery with Explantation of Continuous-Flow Left Ventricular Assist Device after 5 Years of Support
por: Critsinelis, Andre, et al.
Publicado: (2018)

Impact of an Accessory for Left Ventricular Assist Devices on Device Flow and Pressure Head In Vitro
por: Meissner, Florian, et al.
Publicado: (2023)

White blood cell count is not associated with flow-mediated vasodilation or nitroglycerine-induced vasodilation
por: Kishimoto, Shinji, et al.
Publicado: (2022)

Continuous‐flow left ventricular assist devices: Management in the emergency department
por: Hockstein, Maxwell A.
Publicado: (2020)

In Full Flow: Left Ventricular Assist Device Infections in the Modern Era
por: Zinoviev, Radoslav, et al.
Publicado: (2020)

Characteristics of strokes associated with centrifugal flow left ventricular assist devices
por: Inamullah, Ovais, et al.
Publicado: (2021)

Endocrine Challenges in Patients with Continuous-Flow Left Ventricular Assist Devices
por: Martucci, Gennaro, et al.
Publicado: (2021)

Gastrointestinal bleeding on continuous‐flow left ventricular assist device therapy
por: Hammer, Yoav, et al.
Publicado: (2023)

Impact of gender in patients with continuous-flow left ventricular assist device therapy in end-stage heart failure
por: Zubarevich, Alina, et al.
Publicado: (2021)

Modulation of Habit Formation by Levodopa in Parkinson's Disease
por: Marzinzik, Frank, et al.
Publicado: (2011)

“Cueing” for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Schaeffer, Eva, et al.
Publicado: (2016)

Dopamine and Levodopa Prodrugs for the Treatment of Parkinson’s Disease
por: Haddad, Fatma, et al.
Publicado: (2017)

Successful Utilization of Levodopa in HIV-Induced Parkinsonism
por: Almajali, Mohammad, et al.
Publicado: (2020)

Mechanisms of peripheral levodopa resistance in Parkinson’s disease
por: Beckers, Milan, et al.
Publicado: (2022)

Determinants of Levodopa Responsiveness in Patients with Vascular Parkinsonism
por: Goyal, Sheetal, et al.
Publicado: (2022)

Comparison of Endothelial Progenitor Cells in Parkinson's Disease Patients Treated with Levodopa and Levodopa/COMT Inhibitor
por: Lee, Phil Hyu, et al.
Publicado: (2011)

Validation of numerically simulated ventricular flow patterns during left ventricular assist device support
por: Ghodrati, Mojgan, et al.
Publicado: (2020)

Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmia in Continuous-Flow Left Ventricular Assist Device
por: Vlismas, Peter P., et al.
Publicado: (2021)

24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson’s disease
por: Cruse, Belinda, et al.
Publicado: (2018)

Single-Center Experience With Protocolized Treatment of Left Ventricular Assist Device Infections
por: Verkaik, Nelianne J., et al.
Publicado: (2022)

Unusual embolization of a pacemaker lead fragment during lead extraction
por: Yap, Sing-Chien, et al.
Publicado: (2015)

Systematic review and meta-analysis comparing low-flow duration of extracorporeal and conventional cardiopulmonary resuscitation
por: Mandigers, Loes, et al.
Publicado: (2022)

(18)F-FDG PET/CT in the Diagnosis and Management of Continuous Flow Left Ventricular Assist Device Infections: A Case Series and Review of the Literature
por: Akin, Sakir, et al.
Publicado: (2018)

Late Complications Following Continuous-Flow Left Ventricular Assist Device Implantation
por: Grimm, Joshua C., et al.
Publicado: (2015)

Exercise gas exchange in continuous-flow left ventricular assist device recipients
por: Mezzani, Alessandro, et al.
Publicado: (2018)

Prevalence of Cerebral Microbleeds in Patients With Continuous‐Flow Left Ventricular Assist Devices
por: Yoshioka, Daisuke, et al.
Publicado: (2017)

Metabolic Dysfunction in Continuous‐Flow Left Ventricular Assist Devices Patients and Outcomes
por: Nguyen, Ann B., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_701mgtcntlmf59fo17pjou7qgn